A Tribute to George A. Jacoby

Same author

Enhancing clinical utility of AI-based antimicrobial resistance models: a perspective.

mBio·2026

Same author

Standardized numbering and alignment of the KPC family of β-lactamases.

Antimicrobial agents and chemotherapy·2026

Same author

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant Pseudomonas aeruginosa and clinical implications in the prospective observational Pseudomonas study.

Antimicrobial agents and chemotherapy·2026

Same author

Sulbactam-durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia-associated Fitz-Hugh-Curtis syndrome.

Antimicrobial agents and chemotherapy·2026

Same author

Role of Ambler Position 104 in Defining Substrate Specificity in the KPC Family of β-Lactamases.

ACS infectious diseases·2026

Same author

A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

mBio·2026

Same journal

In vitro antibacterial activity of gepotidacin in combination with other antimicrobial agents against Neisseria gonorrhoeae isolates.

Antimicrobial agents and chemotherapy·2026

Same journal

Development of domain-specific probes of Plasmodium falciparum heat shock protein 70-1.

Antimicrobial agents and chemotherapy·2026

Same journal

Addressing therapeutic options for KPC-3-producing ST307-Klebsiella pneumoniae: insights from in vitro evolution and mutant prevention strategies.

Antimicrobial agents and chemotherapy·2026

Same journal

Indole-based hybrids target both asexual parasites and gametocytes of Plasmodium falciparum and synergize with lumefantrine.

Antimicrobial agents and chemotherapy·2026

Same journal

Lineage-specific loss of the type VI secretion system in Acinetobacter baumannii ST19 is associated with reduced accessory genome content.

Antimicrobial agents and chemotherapy·2026

Same journal

Genomic diversity and topical antimicrobial resistance in Staphylococcus aureus from clinical and carriage populations in the New York-New Jersey region.

Antimicrobial agents and chemotherapy·2026

Related Experiment Videos

A Tribute to George A. Jacoby

Related Concept Videos

Enhancing clinical utility of AI-based antimicrobial resistance models: a perspective.

Standardized numbering and alignment of the KPC family of β-lactamases.

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study.

Sulbactam-durlobactam and cefiderocol combination treatment of <i>Burkholderia cenocepacia</i>-associated Fitz-Hugh-Curtis syndrome.

Role of Ambler Position 104 in Defining Substrate Specificity in the KPC Family of β-Lactamases.

A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

<i>In vitro</i> antibacterial activity of gepotidacin in combination with other antimicrobial agents against <i>Neisseria gonorrhoeae</i> isolates.

Development of domain-specific probes of <i>Plasmodium falciparum</i> heat shock protein 70-1.

Addressing therapeutic options for KPC-3-producing ST307-<i>Klebsiella pneumoniae</i>: insights from <i>in vitro</i> evolution and mutant prevention strategies.

Indole-based hybrids target both asexual parasites and gametocytes of <i>Plasmodium falciparum</i> and synergize with lumefantrine.

Lineage-specific loss of the type VI secretion system in <i>Acinetobacter baumannii</i> ST19 is associated with reduced accessory genome content.

Genomic diversity and topical antimicrobial resistance in <i>Staphylococcus aureus</i> from clinical and carriage populations in the New York-New Jersey region.

Related Experiment Videos

A Tribute to George A. Jacoby

Related Concept Videos

Related Articles

Enhancing clinical utility of AI-based antimicrobial resistance models: a perspective.

Standardized numbering and alignment of the KPC family of β-lactamases.

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study.

Sulbactam-durlobactam and cefiderocol combination treatment of <i>Burkholderia cenocepacia</i>-associated Fitz-Hugh-Curtis syndrome.

Role of Ambler Position 104 in Defining Substrate Specificity in the KPC Family of β-Lactamases.

A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

<i>In vitro</i> antibacterial activity of gepotidacin in combination with other antimicrobial agents against <i>Neisseria gonorrhoeae</i> isolates.

Development of domain-specific probes of <i>Plasmodium falciparum</i> heat shock protein 70-1.

Addressing therapeutic options for KPC-3-producing ST307-<i>Klebsiella pneumoniae</i>: insights from <i>in vitro</i> evolution and mutant prevention strategies.

Indole-based hybrids target both asexual parasites and gametocytes of <i>Plasmodium falciparum</i> and synergize with lumefantrine.

Lineage-specific loss of the type VI secretion system in <i>Acinetobacter baumannii</i> ST19 is associated with reduced accessory genome content.

Genomic diversity and topical antimicrobial resistance in <i>Staphylococcus aureus</i> from clinical and carriage populations in the New York-New Jersey region.